How to Play Hologic Stock Post Q1 Earnings and Progress on Buyout?

Key Takeaways Hologic's $18.3B private takeover deal won shareholder and China SAMR approval, nearing completion.HOLX Q1 revenues rose 2.5%, but missed estimates as Breast Health sales slipped and tariffs hit margins.Hologic shares trade near the $76 cash offer, implying just 1.3% upside from the current levels.Hologic’s (HOLX) $18.3 billion private takeover deal by Blackstone and TPG is progressing toward completion. Announced in October 2025 after months of market speculation, the transaction is said to r ...